Carcillo-lead-art
Humanize From Discovery Institute's Center on Human Exceptionalism
Share
Facebook
Twitter/X
LinkedIn
Flipboard
Print
Email

Daniel Carcillo on Psychedelics as a Treatment for Depression and Traumatic Brain Injury

Season
4
Episode
5
With
Wesley J. Smith
Guest(s)
Daniel Carcillo
Duration
58:02
Download
Audio File (79.69M)
Share
Facebook
Twitter/X
LinkedIn
Flipboard
Print
Email

People with serious mental health issues often face years, if not a lifetime, of debilitating symptoms. These traumas can sometimes be difficult to treat, much less cure. And that has some people looking for new avenues of care beyond standard medicines, including — controversially — psychedelic substances such as Psilocybin, LSD, and the like.

Enthusiasts believe that these substances offer so much hope that they are devoting their lives and careers to this burgeoning field of care. One of these is former professional hockey star, Daniel Carcillo — a 2-time Stanley Cup winner with the Chicago Blackhawks — who was diagnosed with post-concussion syndrome and traumatic brain injury (TBI) following his 10-year career in the NHL. After years of suffering from neurological issues, he found solace in psychedelic medicine which traditional pharmaceuticals could not provide.

Today, Carcillo is an advocate on behalf of TBI survivors and those dealing with mental health challenges. He is vocal about the inadequacies of America’s healthcare system, which is driving some patients to explore novel psychedelic treatments.

Toward this end, he co-founded Healing Realty Trust (HRT), a real estate investment trust investing in the clinical infrastructure that he hopes will help unlock the new industry’s growth and help millions of people access these therapies.

Discussions such as the one you are about to hear are important in developing a better understanding of an ongoing area of medical investigation with the potential to ameliorate difficult medical and psychiatric conditions. Indeed, clinical trials are already being undertaken using psychedelics and the FDA has granted some of these substances its “breakthrough status” allowing fast tracking of potential approval processes. At the very least, it appears that some psychedelics may offer a potential new approach to mitigating the suffering of millions of people.

It must be emphasized that Wesley is not a doctor, nor is Mr. Carcillo. Nothing that was discussed in the interview should be considered medical advice and Mr. Carcillo’s appearance on Humanize does not constitute Wesley’s or Discovery Institute’s endorsement of his perspective.

Related Resources

Wesley J. Smith

Chair and Senior Fellow, Center on Human Exceptionalism
Wesley J. Smith is Chair and Senior Fellow at the Discovery Institute’s Center on Human Exceptionalism. Wesley is a contributor to National Review and is the author of 14 books, in recent years focusing on human dignity, liberty, and equality. Wesley has been recognized as one of America’s premier public intellectuals on bioethics by National Journal and has been honored by the Human Life Foundation as a “Great Defender of Life” for his work against suicide and euthanasia. Wesley’s most recent book is Culture of Death: The Age of “Do Harm” Medicine, a warning about the dangers to patients of the modern bioethics movement.
Tags
Daniel Carcillo
Humanize
psychedelics
Wesley J. Smith